{"id":"https://openalex.org/W7220720045","doi":"https://doi.org/10.64898/2026.10.04.26364699","title":"A Multivariable Mixed-Effects Framework for Predicting Disease Progression in Acute Myeloid Leukemia Using Peripheral Hematology, FLT3 Expression, and Patient Compliance","display_name":"A Multivariable Mixed-Effects Framework for Predicting Disease Progression in Acute Myeloid Leukemia Using Peripheral Hematology, FLT3 Expression, and Patient Compliance","publication_year":2026,"publication_date":"2026-10-06","ids":{"openalex":"https://openalex.org/W7220720045","doi":"https://doi.org/10.64898/2026.10.04.26364699"},"language":"en","primary_location":{"id":"doi:10.64898/2026.10.04.26364699","doi":"https://doi.org/10.64898/2026.10.04.26364699","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.10.04.26364699","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/10/06/2026.10.04.26364699.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.medrxiv.org/content/medrxiv/early/2026/10/06/2026.10.04.26364699.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5157744524","display_name":"Mohammad Mahdi Amiri Dumar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270669","display_name":"Research Institute for Gastroenterology and Liver Diseases","ror":"https://ror.org/014xcbd14","country_code":"IR","type":"facility","lineage":["https://openalex.org/I4405270669"]},{"id":"https://openalex.org/I58048189","display_name":"Shahid Beheshti University of Medical Sciences","ror":"https://ror.org/034m2b326","country_code":"IR","type":"education","lineage":["https://openalex.org/I58048189"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Mohammad Mahdi Amiri Dumar","raw_affiliation_strings":["Gastroenterology and Liver Disease Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gastroenterology and Liver Disease Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran","institution_ids":["https://openalex.org/I4405270669","https://openalex.org/I58048189"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035258051","display_name":"Mitra Aghajani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Mitra Aghajani","raw_affiliation_strings":["University of Alborz, Department of Paramedical Sciences, Karaj, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alborz, Department of Paramedical Sciences, Karaj, Iran","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5035258051"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/disease-progression-prediction","display_name":"disease progression prediction","score":0.9269999861717224},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.7749999761581421},{"id":"https://openalex.org/keywords/white-blood-cell-count","display_name":"white blood cell count","score":0.9409999847412109},{"id":"https://openalex.org/keywords/hemoglobin","display_name":"hemoglobin","score":0.847000002861023},{"id":"https://openalex.org/keywords/npm1","display_name":"NPM1","score":0.9459999799728394},{"id":"https://openalex.org/keywords/dnmt3a","display_name":"DNMT3A","score":0.9990000128746033},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8809999823570251},{"id":"https://openalex.org/keywords/long-term-monitoring","display_name":"long-term monitoring","score":0.45899999141693115},{"id":"https://openalex.org/keywords/generalized-linear-mixed-models","display_name":"generalized linear mixed models","score":0.7870000004768372},{"id":"https://openalex.org/keywords/disease-related-mortality","display_name":"disease-related mortality","score":0.5339999794960022},{"id":"https://openalex.org/keywords/minimally-invasive-monitoring","display_name":"minimally invasive monitoring","score":0.6520000100135803}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8464999794960022},{"id":"https://openalex.org/C160798450","wikidata":"https://www.wikidata.org/wiki/Q4230870","display_name":"Concordance","level":2,"score":0.6869999766349792},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6193000078201294},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5651999711990356},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.5195000171661377},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.49959999322891235},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.48420000076293945},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.48249998688697815},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.47029998898506165},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.44760000705718994},{"id":"https://openalex.org/C2778917026","wikidata":"https://www.wikidata.org/wiki/Q43041","display_name":"Hemoglobin","level":2,"score":0.4074999988079071},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.39640000462532043},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.39579999446868896},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3792000114917755},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3450999855995178},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.34130001068115234},{"id":"https://openalex.org/C2776376844","wikidata":"https://www.wikidata.org/wiki/Q886518","display_name":"Complete blood count","level":2,"score":0.34049999713897705},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.33500000834465027},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.3336000144481659},{"id":"https://openalex.org/C46762472","wikidata":"https://www.wikidata.org/wiki/Q178648","display_name":"Peripheral","level":2,"score":0.33250001072883606},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.326200008392334},{"id":"https://openalex.org/C27403532","wikidata":"https://www.wikidata.org/wiki/Q5532474","display_name":"Generalized estimating equation","level":2,"score":0.31060001254081726},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.3100000023841858},{"id":"https://openalex.org/C3019917304","wikidata":"https://www.wikidata.org/wiki/Q886518","display_name":"Blood count","level":2,"score":0.30550000071525574},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3034999966621399},{"id":"https://openalex.org/C102959455","wikidata":"https://www.wikidata.org/wiki/Q7313954","display_name":"Repeated measures design","level":2,"score":0.301800012588501},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.28349998593330383},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.27970001101493835},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.2736999988555908},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.2732999920845032},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.27239999175071716},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.2581999897956848},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.251800000667572}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.64898/2026.10.04.26364699","doi":"https://doi.org/10.64898/2026.10.04.26364699","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.10.04.26364699","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/10/06/2026.10.04.26364699.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.64898/2026.10.04.26364699","doi":"https://doi.org/10.64898/2026.10.04.26364699","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.10.04.26364699","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/10/06/2026.10.04.26364699.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7220720045.pdf","grobid_xml":"https://content.openalex.org/works/W7220720045.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W2003578346","https://openalex.org/W2783450169","https://openalex.org/W2887033855","https://openalex.org/W2896480326","https://openalex.org/W2903460580","https://openalex.org/W2909346948","https://openalex.org/W2912768031","https://openalex.org/W3016364455","https://openalex.org/W3026538346","https://openalex.org/W3080935763","https://openalex.org/W3114932971","https://openalex.org/W4296183014","https://openalex.org/W4300818684","https://openalex.org/W4403471016","https://openalex.org/W4407346742","https://openalex.org/W4408056415","https://openalex.org/W4411844337","https://openalex.org/W4411851197","https://openalex.org/W4411926265","https://openalex.org/W4415236149","https://openalex.org/W4415773382","https://openalex.org/W4417442354","https://openalex.org/W7154593842","https://openalex.org/W7167804019","https://openalex.org/W7221590435"],"related_works":["https://openalex.org/W2982232092","https://openalex.org/W2039974561","https://openalex.org/W2152786876","https://openalex.org/W2989465459","https://openalex.org/W2045169439","https://openalex.org/W4410957160","https://openalex.org/W3216139989","https://openalex.org/W2097302702","https://openalex.org/W2596288707","https://openalex.org/W4416982040"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"The":[2,132],"clinical":[3,134,245,303],"course":[4],"of":[5,81,103],"acute":[6],"leukemias":[7],"and":[8,21,33,44,64,96,121,129,178,202,229,254,262,267,288],"related":[9],"hematologic":[10,56,260,283,315],"neoplasms":[11],"is":[12],"defined":[13],"by":[14],"aggressive":[15],"clonal":[16],"proliferation,":[17],"severe":[18],"hematopoietic":[19],"disruption,":[20],"recurrent":[22],"molecular":[23,115,249,286],"alterations.":[24],"Although":[25],"serial":[26,86],"bone":[27,199],"marrow":[28,200],"biopsies,":[29],"multiparameter":[30],"flow":[31],"cytometry,":[32],"next-generation":[34],"sequencing":[35],"remain":[36],"standard":[37],"surveillance":[38],"modalities,":[39],"procedural":[40],"invasiveness,":[41],"high":[42],"costs,":[43],"operational":[45],"turnaround":[46],"times":[47],"limit":[48],"their":[49],"frequency.":[50],"Minimally":[51],"invasive,":[52],"scalable":[53,308],"biomarkers\u2014integrating":[54],"routine":[55,259],"indices,":[57,284],"targeted":[58,125,248,285],"gene":[59],"expression,":[60],"circulating":[61],"oncoprotein":[62],"levels,":[63],"patient":[65],"compliance":[66],"metrics\u2014may":[67],"provide":[68,291],"an":[69,306],"accessible":[70,281],"framework":[71],"for":[72,158,310],"dynamic":[73],"monitoring.":[74],"Methods":[75],"In":[76],"this":[77],"longitudinal":[78,137],"cohort":[79],"study":[80],"66":[82],"patients":[83],"across":[84],"272":[85],"encounters":[87],"(discrete":[88],"follow-up":[89],"intervals:":[90],"days":[91],"0,":[92],"14,":[93],"41,":[94],"71,":[95],"78),":[97],"we":[98],"assessed":[99,171],"the":[100,173,179],"prognostic":[101,293],"value":[102],"peripheral":[104,282],"complete":[105],"blood":[106,109],"counts":[107],"(white":[108],"cell":[110],"count":[111,213],"[WBC],":[112],"hemoglobin":[113,189],"[Hb]),":[114],"indicators":[116],"(":[117,191,251],"FLT3,":[118],"NPM1":[119],",":[120],"DNMT3A":[122],"transcript":[123],"levels;":[124],"soluble":[126,255],"FLT3":[127,252],"quantification),":[128],"medication":[130,231,289],"adherence.":[131],"primary":[133],"endpoint":[135],"was":[136,170],"progression":[138],"to":[139,156],"critical":[140],"deterioration":[141],"or":[142],"disease-related":[143],"mortality.":[144],"Generalized":[145],"linear":[146],"mixed-effects":[147,207],"models":[148,271],"(GLMM)":[149],"with":[150,188,258],"patient-specific":[151],"random":[152],"intercepts":[153],"were":[154,163],"constructed":[155],"account":[157],"intra-subject":[159],"repeated":[160],"measures.":[161],"Predictors":[162],"standardized":[164],"per":[165,220],"1-SD":[166,221],"increment.":[167],"Model":[168],"performance":[169],"via":[172],"Akaike":[174],"Information":[175],"Criterion":[176],"(AIC)":[177],"Concordance":[180],"index":[181],"(C-index).":[182],"Results":[183],"Leukocyte":[184],"expansion":[185],"correlated":[186],"inversely":[187],"concentration":[190],"r":[192],"=":[193,218,234,277],"-0.877,":[194],"p":[195,226,239],"<":[196,227,240],"0.001),":[197],"reflecting":[198],"infiltration":[201],"secondary":[203],"erythroid":[204],"suppression.":[205],"Multivariable":[206],"modeling":[208],"confirmed":[209],"that":[210],"elevated":[211],"WBC":[212],"(adjusted":[214],"odds":[215],"ratio":[216],"[aOR]":[217],"1.52":[219],"increase;":[222],"95%":[223,236],"CI:":[224,237],"1.24\u20131.86;":[225],"0.001)":[228,241],"reduced":[230],"adherence":[232,263,290],"(aOR":[233],"0.58;":[235],"0.44\u20130.76;":[238],"independently":[242],"predicted":[243],"adverse":[244],"transition.":[246],"Integrating":[247,298],"markers":[250],"expression":[253],"protein":[256],"levels)":[257],"indices":[261],"demonstrated":[264],"superior":[265],"calibration":[266],"discrimination":[268],"over":[269],"single-domain":[270],"(\u0394AIC":[272],"\u2265":[273],"116;":[274],"Harrell\u2019s":[275],"C-index":[276],"0.81).":[278],"Conclusions":[279],"Readily":[280],"quantification,":[287],"complementary":[292],"information":[294],"regarding":[295],"disease":[296],"activity.":[297],"these":[299],"low-burden":[300],"parameters":[301],"into":[302],"workflows":[304],"offers":[305],"efficient,":[307],"paradigm":[309],"early":[311],"risk":[312],"stratification":[313],"in":[314],"malignancies.":[316]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-10-07T00:00:00"}